Abivax S.A. (AAVXF) scores 26 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $-87.45, representing a 32% premium to fair value.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.